Hughes Hubbard & Reed LLP represented Cyclerion Therapeutics in the deal. Cyclerion Therapeutics (NASDAQ: CYCN) announced the company’s sale of the rights to two drugs used...
You must be a Standard 1 Year member to access this content.
Hughes Hubbard & Reed represented Kensington Capital Acquisition Corp. IV in the transaction while Wilson Sonsini represented Amprius Technologies. Kensington Capital Acquisition Corp. IV executed its business...
You must be a Standard 1 Year member to access this content.
Hughes Hubbard and Parquet & Asociados represented the Republic of Paraguay. Cleary Gottlieb Steen & Hamilton and Estudio Jurídico Gross Brown represented Citigroup Global Markets Inc....
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP and Loyens & Loeff represented Wallbox, while Cuatrecasas, Hughes Hubbard & Reed and Houthoff represented Kensington Capital Acquisition Corp. II in the...
You must be a Standard 1 Year member to access this content.
Hughes Hubbard & Reed LLP represented United Airlines in the transaction. Airlines, Inc. in a $10.75 billion senior secured debt financing, which closed on April 21,...
You must be a Standard 1 Year member to access this content.
Hughes Hubbard & Reed LLP represented ANI Pharmaceuticals in the transaction. ANI Pharmaceuticals signed an agreement to acquire Novitium Pharma for $89.5 million in cash and $74 million...
You must be a Standard 1 Year member to access this content.
